Generation Bio Co.
GBIO
$0.3916
$0.01734.62%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -44.56% | 84.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -44.56% | 84.65% | |||
| Cost of Revenue | 2.89% | -8.14% | |||
| Gross Profit | -86.18% | 51.19% | |||
| SG&A Expenses | -0.66% | -3.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.08% | -5.95% | |||
| Operating Income | -21.70% | 23.01% | |||
| Income Before Tax | -39.63% | 25.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -39.63% | 25.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -39.63% | 25.05% | |||
| EBIT | -21.70% | 23.01% | |||
| EBITDA | -23.37% | 24.03% | |||
| EPS Basic | -39.54% | 25.30% | |||
| Normalized Basic EPS | -28.23% | 25.10% | |||
| EPS Diluted | -39.54% | 25.30% | |||
| Normalized Diluted EPS | -28.23% | 25.10% | |||
| Average Basic Shares Outstanding | 0.08% | 0.31% | |||
| Average Diluted Shares Outstanding | 0.08% | 0.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||